Clinical Trials Using Senolytics The enthusiasm for senescent cell clearance across diseases of aging, along with a therapeutic approach that could be translated to patients, led to the first clinical trial of senolytic therapy (D+Q) in adults with idiopathic pulmonary fibrosis (IPF)
The purity of the standard -EC was estimated to 66% from the comparison on HPLC analysis between the standard and the purified -EC
Sikiric P, Boban Blagai A, Strbe S, Beketic Oreskovic L, Oreskovic I, et al
It is thought that understanding these mechanisms will enable the development of new therapeutic agents and different treatment strategies
First, lets look at testing options, and then Ill explain multiple research-backed ways of lowering Lp(a) either with diet, natural supplements, or medications